These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9678647)

  • 1. Locomotor stereotypy produced by dexbenzetimide and scopolamine is reduced by SKF 83566, not sulpiride.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1998 Jul; 60(3):639-44. PubMed ID: 9678647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1015-9. PubMed ID: 9408208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions.
    Peacock L; Gerlach J
    Biol Psychiatry; 2001 Oct; 50(7):501-9. PubMed ID: 11600103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine produces locomotor stereotypy in an open field but apomorphine does not.
    Mueller K; Peel JL
    Pharmacol Biochem Behav; 1990 Jul; 36(3):613-7. PubMed ID: 2377661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.
    Itoh J; Ukai M; Kameyama T
    Eur J Pharmacol; 1993 Sep; 241(1):99-104. PubMed ID: 7901037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus.
    Mathur A; Shandarin A; LaViolette SR; Parker J; Yeomans JS
    Brain Res; 1997 Nov; 775(1-2):144-55. PubMed ID: 9439838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
    Shen MY; Perreault ML; Fan T; George SR
    Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
    J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
    Ninan I; Kulkarni SK
    Psychopharmacology (Berl); 1998 Feb; 135(3):311-7. PubMed ID: 9498736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats.
    Meyer ME; Cottrell GA; Van Hartesveldt C; Potter TJ
    Pharmacol Biochem Behav; 1993 Feb; 44(2):429-32. PubMed ID: 8446676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F; Meller E
    Brain Res; 1989 Dec; 504(2):276-83. PubMed ID: 2574622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Eur J Pharmacol; 1998 May; 350(1):39-45. PubMed ID: 9683012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.